Metabolic Weight-Loss Stack
"This stack sets the metabolic code so that when we sculpt externally, the body supports it internally."
Stack Overview
About This Stack
Built to safely accelerate body fat reduction while preserving muscle, often in preparation for surgery or as part of a patient's wellness goals. In the Emer Method context, it is used to "pre-age" or pre-condition the body — getting a patient to lose visceral fat and improve insulin sensitivity before a body contouring surgery so that healing and results are optimized. It aligns with pillars of suppressing chaos (by improving metabolic parameters that cause inflammation) and restoring energy (by enhancing mitochondrial function after weight loss). GLP-1 receptor agonists are the primary tools here, complemented by AOD-9604 for stubborn fat deposits and tesofensine for central appetite control.
Composition
What's In This Stack
Core GLP-1 agonist — mimics incretin hormones, leading to reduced appetite, slower gastric emptying, and improved insulin secretion resulting in significant weight loss. Also reduces systemic inflammation and improves metabolic markers like HbA1c. Used as "safe body-fat decline supporting surgical/laser windows."
Dose: 0.25 mg SC weekly titrated up to ~2.4 mg weekly for semaglutide over ~8+ weeks. Alternatively Tirzepatide (dual GIP/GLP-1 agonist) titrated to e.g. 10–15 mg weekly.
Route: Subcutaneous self-injection (abdomen)
Dual GIP/GLP-1 agonist providing synergistic appetite suppression and insulin modulation via two incretin pathways. Produces greater weight loss than GLP-1 alone by targeting complementary appetite pathways. Used as primary or substitute for semaglutide depending on patient profile.
Dose: Titrated to e.g. 10–15 mg weekly
Route: Subcutaneous self-injection (abdomen)
Modified fragment of human GH (amino acids 176–191) — enhances lipolysis and inhibits new fat formation via the beta-3 adrenergic pathway in adipose tissue. Does not affect IGF-1 or blood sugar. Used for stubborn fat and injury repair contexts; can be injected subcutaneously near resistant fat deposits. Shines in "fine-tuning" fat loss without appetite change.
Dose: 300 mcg SC daily
Route: Subcutaneous (near resistant fat deposits, or systemic)
Novel triple monoamine reuptake inhibitor (SNDRI) — profoundly suppressing appetite and slightly increasing resting energy expenditure by silencing GABAergic appetite neurons and boosting pro-satiety signaling. Used as adjunct in a "stacked attack" on obesity, where multiple pathways are hit. Emer calls it "a medical-grade willpower boost, but we'll use it wisely and short-term."
Dose: 0.25–0.5 mg oral daily (women often start at 0.25 mg vs men at 0.5 mg)
Route: Oral
Protocol
Treatment Protocol
Initiated 8–12 weeks before an elective high-impact procedure if patient has excess weight or metabolic issues. GLP-1 titrated over 8+ weeks. AOD-9604 added for patients who plateau or who cannot tolerate GLP-1s. Tesofensine used short-term (1–2 week "tesofensine challenge" first, then 3-month course if tolerated). Weekly check-ins; blood pressure and glucose monitored. Lifestyle concurrently optimized: 1.6–2.2 g/kg/day protein, resistance training, fiber 25–35 g/day.
Patient Fit
Ideal For
- Patients with obesity or "stubborn weight" pre-surgery
- Patients who cannot tolerate injectables (tesofensine oral alternative)
- Pre-body contouring surgical optimization (metabolic prehabilitation)
- Patients with metabolic syndrome, insulin resistance, or pre-diabetes
- Post-liposuction maintenance to prevent fat rebound
Results
Clinical Outcomes
Significant weight reductions — e.g. 20–30 lbs over 3 months pre-op, making previously "inoperable" patients (due to high BMI) candidates for safe surgery. Blood sugar and cholesterol levels improve, correlating with better wound healing. The stack also leads to less fat re-deposition after lipo, since the patient's appetite and habits are changed. Many GLP-1 patients paradoxically feel more energetic once they adjust, likely due to weight loss and metabolic relief.
Begin Your RECODEX™ Protocol
All peptide stacks are physician-supervised and custom-tailored.
Request Consultation
